Realcan Pharmaceutical Group Co Ltd
SZSE:002589
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Realcan Pharmaceutical Group Co Ltd
SZSE:002589
|
CN |
|
A
|
Affluent Foundation Holdings Ltd
HKEX:1757
|
HK |
|
Donkeyrepublic Holding A/S
F:6UJ
|
DK |
|
S
|
Scope Fluidics SA
WSE:SCP
|
PL |
|
Bancolombia SA
NYSE:CIB
|
CO |
|
P
|
Pomi Frutas SA - em Recuperacao Judicial
BOVESPA:FRTA3
|
BR |
|
Ministop Co Ltd
TSE:9946
|
JP |
|
N
|
NZME Ltd
ASX:NZM
|
NZ |
|
National Bank Holdings Corp
NYSE:NBHC
|
US |
|
BBX Minerals Ltd
ASX:BBX
|
AU |
|
Shenzhen Huijie Group Co Ltd
SZSE:002763
|
CN |
|
N G Industries Ltd
BSE:530897
|
IN |
|
E
|
EOFlow Co Ltd
KOSDAQ:294090
|
KR |
|
Kose Corp
OTC:KSRYY
|
JP |
|
Zhejiang Hisoar Pharmaceutical Co Ltd
SZSE:002099
|
CN |
|
C
|
China Shineway Pharmaceutical Group Ltd
OTC:CSWYF
|
CN |
|
E
|
ELK-Desa Resources Bhd
KLSE:ELKDESA
|
MY |
|
Health Italia SpA
MIL:HI
|
IT |
|
G
|
Generix Group SA
LSE:0JAW
|
FR |
|
Alpine Summit Energy Partners Inc
XTSX:ALPS.U
|
CA |
|
Belimo Holding AG
SIX:BEAN
|
CH |
|
CMOC Group Ltd
SSE:603993
|
CN |
|
Surge Battery Metals Inc
XTSX:NILI
|
CA |
Wall Street
Price Targets
Price Targets Summary
Realcan Pharmaceutical Group Co Ltd
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is Realcan Pharmaceutical Group Co Ltd's stock price target?
Not Available
Realcan Pharmaceutical Group Co Ltd doesn't have any price targets made by Wall Street professionals.
What is Realcan Pharmaceutical Group Co Ltd's Revenue forecast?
Projected CAGR
37%
For the last 13 years the
compound annual growth rate for
Realcan Pharmaceutical Group Co Ltd's revenue is
7%.
The projected
CAGR
for the next 5 years is
37%.
What is Realcan Pharmaceutical Group Co Ltd's Operating Income forecast?
Projected CAGR
159%
For the last 13 years the
compound annual growth rate for
Realcan Pharmaceutical Group Co Ltd's operating income is
-17%.
The projected
CAGR
for the next 6 years is
159%.
What is Realcan Pharmaceutical Group Co Ltd's Net Income forecast?
Projected CAGR
120%
For the last 13 years the
compound annual growth rate for
Realcan Pharmaceutical Group Co Ltd's net income is
-8%.
The projected
CAGR
for the next 5 years is
120%.
